#ADVENZYMES : Board of Directors of SciTech Specialities Private Limited (a 51% subsidiary) has approved:
(i) Investment of SciTech in Vecteng SciTech (Pty) Ltd, South Africa (“Vecteng”) by acquiring / subscribing to 14% of paid up share capital of Vecteng for an amount not exceeding USD 14500
(ii) Authority to sign the Shareholder’s Agreement with Vectang